Galactooligosaccharide supplementation provides protection against Citrobacter rodentium-induced colitis without limiting pathogen burden.

about

Commensal Strains Can Promote Intestinal Inflammation via Differential Interleukin-6 Production

P2860

Q57816725-DDF7885A-E7B6-419B-B388-EA6D0AAA68F1

P2860

Galactooligosaccharide supplementation provides protection against Citrobacter rodentium-induced colitis without limiting pathogen burden.

Item

http://www.wikidata.org/entity/Q47284034

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Galactooligosaccharide supplem ...... hout limiting pathogen burden.

@en

Galactooligosaccharide supplem ...... hout limiting pathogen burden.

@nl

type

Item

label

Galactooligosaccharide supplem ...... hout limiting pathogen burden.

@en

Galactooligosaccharide supplem ...... hout limiting pathogen burden.

@nl

prefLabel

Galactooligosaccharide supplem ...... hout limiting pathogen burden.

@en

Galactooligosaccharide supplem ...... hout limiting pathogen burden.

@nl

P1476

Galactooligosaccharide supplem ...... hout limiting pathogen burden.

@en

P2093

Hatem Kittana

http://www.w3.org/2001/XMLSchema#string

Liz A Cody

http://www.w3.org/2001/XMLSchema#string

Maria I Quintero-Villegas

http://www.w3.org/2001/XMLSchema#string

Rafael R Segura Munoz

http://www.w3.org/2001/XMLSchema#string

Robert J Schmaltz

http://www.w3.org/2001/XMLSchema#string

Robert W Hutkins

http://www.w3.org/2001/XMLSchema#string

Rodney A Moxley

http://www.w3.org/2001/XMLSchema#string

P2860

Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice

Disease tolerance as a defense strategy

Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk

Non-canonical inflammasome activation targets caspase-11

Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

Identification of cell surface-exposed proteins involved in the fimbria-mediated adherence of enteroaggregative Escherichia coli to intestinal cells.

Some putative prebiotics increase the severity of Salmonella enterica serovar Typhimurium infection in mice.

Annotation and structural analysis of sialylated human milk oligosaccharides.

Mast cells limit systemic bacterial dissemination but not colitis in response to Citrobacter rodentium

P304

154-162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1099/MIC.0.000593

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

164

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29256851

http://www.w3.org/2001/XMLSchema#string

P932

5884961

http://www.w3.org/2001/XMLSchema#string

Galactooligosaccharide supplementation provides protection against Citrobacter rodentium-induced colitis without limiting pathogen burden.

about

P2860

P2860

Galactooligosaccharide supplementation provides protection against Citrobacter rodentium-induced colitis without limiting pathogen burden.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932